

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.24154940 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.24154940 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.84247802 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.84247802 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.58878307 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.05947865 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.99122271 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.99122271 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.99122271 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95518634 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.81013287 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.73467616 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.65301366 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.59809659 |
| 15 | L-amino acid import (GO:0043092) | 5.58556168 |
| 16 | urea metabolic process (GO:0019627) | 5.56979057 |
| 17 | urea cycle (GO:0000050) | 5.56979057 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 5.55332522 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30076333 |
| 20 | glutamate secretion (GO:0014047) | 5.29621046 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.27595002 |
| 22 | synaptic vesicle maturation (GO:0016188) | 5.26350794 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.20179266 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 5.18003801 |
| 25 | amino acid import (GO:0043090) | 5.17955962 |
| 26 | cysteine metabolic process (GO:0006534) | 5.16331759 |
| 27 | amine catabolic process (GO:0009310) | 5.15896306 |
| 28 | cellular biogenic amine catabolic process (GO:0042402) | 5.15896306 |
| 29 | central nervous system myelination (GO:0022010) | 5.14256064 |
| 30 | axon ensheathment in central nervous system (GO:0032291) | 5.14256064 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.08327622 |
| 32 | sodium ion export (GO:0071436) | 5.07287867 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.04645201 |
| 34 | complement activation, alternative pathway (GO:0006957) | 5.03723909 |
| 35 | regulation of protein activation cascade (GO:2000257) | 5.03165682 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 5.02652891 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.93556906 |
| 38 | protein carboxylation (GO:0018214) | 4.88621902 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88621902 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.87139064 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.85338379 |
| 42 | bile acid metabolic process (GO:0008206) | 4.84275001 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.81326766 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.75224615 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.75224615 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.75224615 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.73893426 |
| 48 | regulation of complement activation (GO:0030449) | 4.73732983 |
| 49 | reverse cholesterol transport (GO:0043691) | 4.71513537 |
| 50 | synaptic vesicle exocytosis (GO:0016079) | 4.69309853 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.65584811 |
| 52 | postsynaptic membrane organization (GO:0001941) | 4.59417647 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.56849018 |
| 54 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.53965863 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.53632941 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 4.49875010 |
| 57 | low-density lipoprotein particle remodeling (GO:0034374) | 4.45459023 |
| 58 | glutamate metabolic process (GO:0006536) | 4.45255357 |
| 59 | potassium ion import (GO:0010107) | 4.44743108 |
| 60 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.33873493 |
| 61 | lysine catabolic process (GO:0006554) | 4.33798424 |
| 62 | lysine metabolic process (GO:0006553) | 4.33798424 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.33702629 |
| 64 | locomotory exploration behavior (GO:0035641) | 4.27414534 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.27329415 |
| 66 | potassium ion homeostasis (GO:0055075) | 4.24291312 |
| 67 | acylglycerol homeostasis (GO:0055090) | 4.24202826 |
| 68 | triglyceride homeostasis (GO:0070328) | 4.24202826 |
| 69 | neurotransmitter uptake (GO:0001504) | 4.23914342 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.23203665 |
| 71 | carnitine metabolic process (GO:0009437) | 4.21549353 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.20705524 |
| 73 | phospholipid efflux (GO:0033700) | 4.20446740 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.20404270 |
| 75 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.19607390 |
| 76 | neurotransmitter secretion (GO:0007269) | 4.18101130 |
| 77 | negative regulation of cholesterol transport (GO:0032375) | 4.14457198 |
| 78 | negative regulation of sterol transport (GO:0032372) | 4.14457198 |
| 79 | cellular ketone body metabolic process (GO:0046950) | 4.11693662 |
| 80 | bile acid and bile salt transport (GO:0015721) | 4.10975807 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 4.10288201 |
| 82 | regulation of synaptic vesicle transport (GO:1902803) | 4.08776460 |
| 83 | neuronal ion channel clustering (GO:0045161) | 4.04571453 |
| 84 | cholesterol efflux (GO:0033344) | 4.02525688 |
| 85 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.99463737 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.98076425 |
| 87 | cellular glucuronidation (GO:0052695) | 3.97828013 |
| 88 | plasma lipoprotein particle clearance (GO:0034381) | 3.95312647 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.94775530 |
| 90 | cellular sodium ion homeostasis (GO:0006883) | 3.94651162 |
| 91 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.93832670 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.91232137 |
| 93 | glycine metabolic process (GO:0006544) | 3.89414055 |
| 94 | arginine metabolic process (GO:0006525) | 3.88543112 |
| 95 | exploration behavior (GO:0035640) | 3.85286978 |
| 96 | vocalization behavior (GO:0071625) | 3.83921647 |
| 97 | gamma-aminobutyric acid transport (GO:0015812) | 3.83712225 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.82884880 |
| 99 | ethanol oxidation (GO:0006069) | 3.82654249 |
| 100 | neuronal action potential propagation (GO:0019227) | 3.81898468 |
| 101 | benzene-containing compound metabolic process (GO:0042537) | 3.78265017 |
| 102 | drug catabolic process (GO:0042737) | 3.77037786 |
| 103 | serine family amino acid biosynthetic process (GO:0009070) | 3.73787361 |
| 104 | C4-dicarboxylate transport (GO:0015740) | 3.71801095 |
| 105 | plasma lipoprotein particle organization (GO:0071827) | 3.71662719 |
| 106 | neuron cell-cell adhesion (GO:0007158) | 3.71202248 |
| 107 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.69902022 |
| 108 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.68896277 |
| 109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.66771967 |
| 110 | acidic amino acid transport (GO:0015800) | 3.66559018 |
| 111 | organic acid catabolic process (GO:0016054) | 3.63882304 |
| 112 | carboxylic acid catabolic process (GO:0046395) | 3.63882304 |
| 113 | neurotransmitter transport (GO:0006836) | 3.63004524 |
| 114 | cerebellar granule cell differentiation (GO:0021707) | 3.60012091 |
| 115 | regulation of bile acid biosynthetic process (GO:0070857) | 3.59354673 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.57989299 |
| 117 | ketone body metabolic process (GO:1902224) | 3.53924381 |
| 118 | complement activation, classical pathway (GO:0006958) | 3.53786555 |
| 119 | fibrinolysis (GO:0042730) | 3.52985018 |
| 120 | exogenous drug catabolic process (GO:0042738) | 3.52419873 |
| 121 | blood coagulation, intrinsic pathway (GO:0007597) | 3.52168470 |
| 122 | omega-hydroxylase P450 pathway (GO:0097267) | 3.51721691 |
| 123 | presynaptic membrane assembly (GO:0097105) | 3.51492489 |
| 124 | complement activation (GO:0006956) | 3.50390010 |
| 125 | cytolysis (GO:0019835) | 3.49221760 |
| 126 | cofactor catabolic process (GO:0051187) | 3.49201501 |
| 127 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.48588063 |
| 128 | protein activation cascade (GO:0072376) | 3.48478734 |
| 129 | protein-lipid complex assembly (GO:0065005) | 3.48111148 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 3.47887268 |
| 131 | 2-oxoglutarate metabolic process (GO:0006103) | 3.47035708 |
| 132 | short-chain fatty acid metabolic process (GO:0046459) | 3.46811214 |
| 133 | uronic acid metabolic process (GO:0006063) | 3.46719778 |
| 134 | glucuronate metabolic process (GO:0019585) | 3.46719778 |
| 135 | urate metabolic process (GO:0046415) | 3.45922618 |
| 136 | regulation of neurotransmitter levels (GO:0001505) | 3.43902368 |
| 137 | epoxygenase P450 pathway (GO:0019373) | 3.43590168 |
| 138 | positive regulation of lipid catabolic process (GO:0050996) | 3.42861824 |
| 139 | presynaptic membrane organization (GO:0097090) | 3.42480764 |
| 140 | acetyl-CoA metabolic process (GO:0006084) | 3.42426994 |
| 141 | cholesterol homeostasis (GO:0042632) | 3.41668270 |
| 142 | aldehyde catabolic process (GO:0046185) | 3.41529426 |
| 143 | cell communication by electrical coupling (GO:0010644) | 3.34984282 |
| 144 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.34240753 |
| 145 | synaptic transmission, glutamatergic (GO:0035249) | 3.32026758 |
| 146 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28868575 |
| 147 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.23483116 |
| 148 | L-glutamate transport (GO:0015813) | 3.20622910 |
| 149 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15592973 |
| 150 | positive regulation of synapse maturation (GO:0090129) | 3.15427817 |
| 151 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.05500439 |
| 152 | positive regulation of dendritic spine development (GO:0060999) | 3.02651268 |
| 153 | neuron-neuron synaptic transmission (GO:0007270) | 3.00628831 |
| 154 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.99161169 |
| 155 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96959553 |
| 156 | protein localization to synapse (GO:0035418) | 2.94460023 |
| 157 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.92430864 |
| 158 | regulation of synaptic plasticity (GO:0048167) | 2.90561057 |
| 159 | regulation of neurotransmitter secretion (GO:0046928) | 2.90235496 |
| 160 | regulation of synapse structural plasticity (GO:0051823) | 2.89360396 |
| 161 | regulation of neurotransmitter transport (GO:0051588) | 2.86949344 |
| 162 | positive regulation of membrane potential (GO:0045838) | 2.85789015 |
| 163 | glutamate receptor signaling pathway (GO:0007215) | 2.84909428 |
| 164 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.83996529 |
| 165 | regulation of female receptivity (GO:0045924) | 2.82210361 |
| 166 | neuromuscular process controlling balance (GO:0050885) | 2.81723528 |
| 167 | synaptic vesicle endocytosis (GO:0048488) | 2.81014250 |
| 168 | long-term synaptic potentiation (GO:0060291) | 2.80892748 |
| 169 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79015999 |
| 170 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.77640278 |
| 171 | oxidative demethylation (GO:0070989) | 2.76978992 |
| 172 | drug metabolic process (GO:0017144) | 2.76373136 |
| 173 | auditory behavior (GO:0031223) | 2.74913683 |
| 174 | sodium ion homeostasis (GO:0055078) | 2.74054719 |
| 175 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68369314 |
| 176 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.67142686 |
| 177 | steroid catabolic process (GO:0006706) | 2.65937383 |
| 178 | positive regulation of neurotransmitter transport (GO:0051590) | 2.65403259 |
| 179 | regulation of neurotransmitter uptake (GO:0051580) | 2.64521607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.28019456 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.10938595 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.03978596 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.73311939 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84998593 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.70900999 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.86700030 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.78408044 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.62160011 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25360448 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74159695 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.47192262 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.45959629 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33903302 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13788272 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13788272 |
| 17 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12431858 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.09617767 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04890899 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02233951 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02106947 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4464250 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99933968 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96432789 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95150961 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.91016346 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.89281063 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67425972 |
| 29 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63968211 |
| 30 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.63525751 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.59210833 |
| 32 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.54471059 |
| 33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38203041 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35474762 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35191860 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35109180 |
| 37 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31015808 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.28698998 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28619028 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22857785 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22399463 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.21864424 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21809792 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17300940 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.14944910 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.14299227 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13204523 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13061144 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09182030 |
| 50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07925950 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07917805 |
| 52 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06412357 |
| 53 | AR_19668381_ChIP-Seq_PC3_Human | 1.06293329 |
| 54 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04716872 |
| 55 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02511908 |
| 56 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99837279 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99701856 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99492508 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98330295 |
| 60 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97306458 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97304751 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97304751 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96895736 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95251487 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95038418 |
| 66 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94614764 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94386161 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94299565 |
| 69 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92827712 |
| 70 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92644329 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92418154 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90580186 |
| 73 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89813708 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87826028 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87100118 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86900058 |
| 77 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86474561 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86048032 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.85453180 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84056359 |
| 81 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.83399553 |
| 82 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.82995392 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82576322 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82276433 |
| 85 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.81769469 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80795947 |
| 87 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79946620 |
| 88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.79789859 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.79529104 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78939470 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78913710 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78534658 |
| 93 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.78028227 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77243853 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76745399 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76625422 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75109982 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73290401 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71011992 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.70686740 |
| 101 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.69475562 |
| 102 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69122470 |
| 103 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.68781733 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.67045565 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66823741 |
| 106 | CBP_21632823_ChIP-Seq_H3396_Human | 0.65835570 |
| 107 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.63310327 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63301769 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.63244335 |
| 110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61998550 |
| 111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.61950782 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60697325 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.60415483 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59989628 |
| 115 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.59851068 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58965862 |
| 117 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.58645166 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.58502889 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.57368395 |
| 120 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.56814498 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.56278077 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.56022619 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.55216673 |
| 124 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.54937212 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.53782875 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.53680755 |
| 127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53551343 |
| 128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.53481674 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.52852170 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52680131 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.52454702 |
| 132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.52340861 |
| 133 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.51976911 |
| 134 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.51732720 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.51333327 |
| 136 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.50852014 |
| 137 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.50750696 |
| 138 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.50454832 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50406372 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50236864 |
| 141 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.50049421 |
| 142 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.49932210 |
| 143 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.49714589 |
| 144 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.49621131 |
| 145 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.49581298 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.49347240 |
| 147 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.49232291 |
| 148 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.48773256 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48736868 |
| 150 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.48678033 |
| 151 | P300_19829295_ChIP-Seq_ESCs_Human | 0.48308825 |
| 152 | AR_25329375_ChIP-Seq_VCAP_Human | 0.47896328 |
| 153 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.47832128 |
| 154 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47733801 |
| 155 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47653841 |
| 156 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.47459783 |
| 157 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47375389 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47182849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.82837576 |
| 2 | MP0005360_urolithiasis | 7.31741966 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.31152755 |
| 4 | MP0005365_abnormal_bile_salt | 5.92374032 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 4.80660734 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.79882008 |
| 7 | MP0005423_abnormal_somatic_nervous | 4.13177239 |
| 8 | MP0003880_abnormal_central_pattern | 4.12469496 |
| 9 | MP0003252_abnormal_bile_duct | 3.90154093 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.76428215 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.63588705 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 3.32015799 |
| 13 | MP0002064_seizures | 3.30476156 |
| 14 | MP0009745_abnormal_behavioral_response | 3.02851845 |
| 15 | MP0001486_abnormal_startle_reflex | 2.94479835 |
| 16 | MP0005670_abnormal_white_adipose | 2.91182181 |
| 17 | MP0005332_abnormal_amino_acid | 2.90022209 |
| 18 | MP0003195_calcinosis | 2.84415269 |
| 19 | MP0009840_abnormal_foam_cell | 2.84220655 |
| 20 | MP0005083_abnormal_biliary_tract | 2.81400108 |
| 21 | MP0002272_abnormal_nervous_system | 2.75198584 |
| 22 | MP0002063_abnormal_learning/memory/cond | 2.68867547 |
| 23 | MP0005451_abnormal_body_composition | 2.58273192 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.56385793 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.44685698 |
| 26 | MP0001968_abnormal_touch/_nociception | 2.41334739 |
| 27 | MP0003879_abnormal_hair_cell | 2.34184680 |
| 28 | MP0009046_muscle_twitch | 2.30972869 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.27986990 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 2.11462129 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 2.10140497 |
| 32 | MP0000609_abnormal_liver_physiology | 2.02991464 |
| 33 | MP0003868_abnormal_feces_composition | 1.97242879 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.96530086 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.96251969 |
| 36 | MP0002736_abnormal_nociception_after | 1.93854336 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.86988940 |
| 38 | MP0000920_abnormal_myelination | 1.85689320 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.82972997 |
| 40 | MP0008569_lethality_at_weaning | 1.82930211 |
| 41 | MP0001984_abnormal_olfaction | 1.79397949 |
| 42 | MP0001970_abnormal_pain_threshold | 1.76741810 |
| 43 | MP0005319_abnormal_enzyme/_coenzyme | 1.74546528 |
| 44 | MP0009697_abnormal_copulation | 1.70541740 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.62175803 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60142403 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.59695617 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.57876553 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.57699610 |
| 50 | MP0001905_abnormal_dopamine_level | 1.56477123 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.44446532 |
| 52 | MP0001764_abnormal_homeostasis | 1.43234462 |
| 53 | MP0002557_abnormal_social/conspecific_i | 1.40117504 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.37559740 |
| 55 | MP0005377_hearing/vestibular/ear_phenot | 1.37190803 |
| 56 | MP0003878_abnormal_ear_physiology | 1.37190803 |
| 57 | MP0003690_abnormal_glial_cell | 1.35266865 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.32514974 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.26753414 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.23696591 |
| 61 | MP0000778_abnormal_nervous_system | 1.23205552 |
| 62 | MP0003632_abnormal_nervous_system | 1.22762143 |
| 63 | MP0005647_abnormal_sex_gland | 1.21771836 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.20638161 |
| 65 | MP0004742_abnormal_vestibular_system | 1.18662854 |
| 66 | MP0001963_abnormal_hearing_physiology | 1.17202036 |
| 67 | MP0004924_abnormal_behavior | 1.16527755 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.16527755 |
| 69 | MP0000955_abnormal_spinal_cord | 1.16259019 |
| 70 | MP0003186_abnormal_redox_activity | 1.15939815 |
| 71 | MP0003634_abnormal_glial_cell | 1.15558714 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.13147264 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.09337732 |
| 74 | MP0002229_neurodegeneration | 1.08660779 |
| 75 | MP0009764_decreased_sensitivity_to | 1.07514422 |
| 76 | MP0009643_abnormal_urine_homeostasis | 1.07325761 |
| 77 | MP0003011_delayed_dark_adaptation | 1.04958460 |
| 78 | MP0003787_abnormal_imprinting | 1.04238642 |
| 79 | MP0000604_amyloidosis | 1.03790597 |
| 80 | MP0009384_cardiac_valve_regurgitation | 1.01202885 |
| 81 | MP0006276_abnormal_autonomic_nervous | 1.00454958 |
| 82 | MP0002254_reproductive_system_inflammat | 0.97668697 |
| 83 | MP0000598_abnormal_liver_morphology | 0.96671500 |
| 84 | MP0009763_increased_sensitivity_to | 0.93980266 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 0.92894470 |
| 86 | MP0003329_amyloid_beta_deposits | 0.89648371 |
| 87 | MP0001661_extended_life_span | 0.87544644 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.82569666 |
| 89 | MP0004270_analgesia | 0.80692589 |
| 90 | MP0005334_abnormal_fat_pad | 0.80544349 |
| 91 | MP0002152_abnormal_brain_morphology | 0.80253569 |
| 92 | MP0003136_yellow_coat_color | 0.79918302 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.78839459 |
| 94 | MP0002822_catalepsy | 0.76817482 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.76211555 |
| 96 | MP0005535_abnormal_body_temperature | 0.75858790 |
| 97 | MP0004130_abnormal_muscle_cell | 0.75466018 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.74904101 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.74839160 |
| 100 | MP0008469_abnormal_protein_level | 0.73545663 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.70958352 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.70250350 |
| 103 | MP0004381_abnormal_hair_follicle | 0.69197048 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.68795007 |
| 105 | MP0005408_hypopigmentation | 0.67459951 |
| 106 | MP0005253_abnormal_eye_physiology | 0.66975511 |
| 107 | MP0002069_abnormal_eating/drinking_beha | 0.65353855 |
| 108 | MP0002184_abnormal_innervation | 0.64195310 |
| 109 | MP0003075_altered_response_to | 0.64047290 |
| 110 | MP0008874_decreased_physiological_sensi | 0.64022640 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.63949188 |
| 112 | MP0004885_abnormal_endolymph | 0.63553865 |
| 113 | MP0000026_abnormal_inner_ear | 0.63529568 |
| 114 | MP0002102_abnormal_ear_morphology | 0.61764993 |
| 115 | MP0001853_heart_inflammation | 0.60364584 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.59966951 |
| 117 | MP0001502_abnormal_circadian_rhythm | 0.58116908 |
| 118 | MP0002971_abnormal_brown_adipose | 0.58064929 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.57913959 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.56228339 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.54511115 |
| 122 | MP0000579_abnormal_nail_morphology | 0.54158598 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.53364414 |
| 124 | MP0004147_increased_porphyrin_level | 0.52185165 |
| 125 | MP0001529_abnormal_vocalization | 0.50586643 |
| 126 | MP0003953_abnormal_hormone_level | 0.50076940 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.50021827 |
| 128 | MP0008872_abnormal_physiological_respon | 0.46428794 |
| 129 | MP0005266_abnormal_metabolism | 0.46182697 |
| 130 | MP0000566_synostosis | 0.45866594 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.45794705 |
| 132 | MP0002928_abnormal_bile_duct | 0.45615815 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.44635922 |
| 134 | MP0005409_darkened_coat_color | 0.44405070 |
| 135 | MP0005166_decreased_susceptibility_to | 0.44147017 |
| 136 | MP0003633_abnormal_nervous_system | 0.43714764 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.42471279 |
| 138 | MP0005395_other_phenotype | 0.42423383 |
| 139 | MP0002168_other_aberrant_phenotype | 0.41296198 |
| 140 | MP0002796_impaired_skin_barrier | 0.40148602 |
| 141 | MP0001756_abnormal_urination | 0.38733379 |
| 142 | MP0005448_abnormal_energy_balance | 0.38259343 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.37269558 |
| 144 | MP0004142_abnormal_muscle_tone | 0.37200781 |
| 145 | MP0009672_abnormal_birth_weight | 0.36974208 |
| 146 | MP0008873_increased_physiological_sensi | 0.36920313 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.36085068 |
| 148 | MP0009115_abnormal_fat_cell | 0.35722727 |
| 149 | MP0001881_abnormal_mammary_gland | 0.35021746 |
| 150 | MP0004043_abnormal_pH_regulation | 0.34368370 |
| 151 | MP0002090_abnormal_vision | 0.33927386 |
| 152 | MP0000230_abnormal_systemic_arterial | 0.32775183 |
| 153 | MP0001440_abnormal_grooming_behavior | 0.31239805 |
| 154 | MP0005646_abnormal_pituitary_gland | 0.30538583 |
| 155 | MP0003631_nervous_system_phenotype | 0.30261729 |
| 156 | MP0001177_atelectasis | 0.29446210 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.28667076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.08758582 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.03957803 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.02270812 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44766665 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.20645707 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 6.05436090 |
| 7 | Xanthomatosis (HP:0000991) | 6.03992278 |
| 8 | Myokymia (HP:0002411) | 5.97420368 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.80109941 |
| 10 | Focal motor seizures (HP:0011153) | 5.41896325 |
| 11 | Complement deficiency (HP:0004431) | 5.30968953 |
| 12 | Diplopia (HP:0000651) | 4.84157311 |
| 13 | Abnormality of binocular vision (HP:0011514) | 4.84157311 |
| 14 | Focal seizures (HP:0007359) | 4.73650633 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.70914723 |
| 16 | Joint hemorrhage (HP:0005261) | 4.56514947 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.51708511 |
| 18 | Action tremor (HP:0002345) | 4.50487434 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.47675923 |
| 20 | Epidermoid cyst (HP:0200040) | 4.43215165 |
| 21 | Hyperammonemia (HP:0001987) | 4.41218221 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.40014018 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34197448 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16163059 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.15891585 |
| 26 | Ketosis (HP:0001946) | 4.13373623 |
| 27 | Hyperglycinemia (HP:0002154) | 4.06176619 |
| 28 | Epileptic encephalopathy (HP:0200134) | 4.02864716 |
| 29 | Hyperglycinuria (HP:0003108) | 3.98315373 |
| 30 | Neurofibrillary tangles (HP:0002185) | 3.98147389 |
| 31 | Fat malabsorption (HP:0002630) | 3.95122462 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.92063719 |
| 33 | Febrile seizures (HP:0002373) | 3.88731202 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.84769208 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84769208 |
| 36 | Atonic seizures (HP:0010819) | 3.82189776 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.79110852 |
| 38 | Abnormality of complement system (HP:0005339) | 3.77887906 |
| 39 | Generalized tonic-clonic seizures (HP:0002069) | 3.69936826 |
| 40 | Increased circulating renin level (HP:0000848) | 3.61666942 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.60525054 |
| 42 | Ankle clonus (HP:0011448) | 3.55150180 |
| 43 | Hypoglycemic coma (HP:0001325) | 3.46786496 |
| 44 | Alopecia of scalp (HP:0002293) | 3.39961790 |
| 45 | Hypercholesterolemia (HP:0003124) | 3.37637463 |
| 46 | Supranuclear gaze palsy (HP:0000605) | 3.36251611 |
| 47 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25360330 |
| 48 | Abnormal eating behavior (HP:0100738) | 3.24375193 |
| 49 | Vascular calcification (HP:0004934) | 3.15801723 |
| 50 | Hyperbilirubinemia (HP:0002904) | 3.14953066 |
| 51 | Intention tremor (HP:0002080) | 3.08541085 |
| 52 | Postural instability (HP:0002172) | 3.07795016 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 3.02605740 |
| 54 | Ketoacidosis (HP:0001993) | 3.02474976 |
| 55 | Myocardial infarction (HP:0001658) | 3.01285286 |
| 56 | Absence seizures (HP:0002121) | 3.00834122 |
| 57 | Steatorrhea (HP:0002570) | 2.98433739 |
| 58 | Hemiplegia (HP:0002301) | 2.98175179 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.96950137 |
| 60 | Hemiparesis (HP:0001269) | 2.96923455 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95678381 |
| 62 | Delayed CNS myelination (HP:0002188) | 2.93279711 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.93028919 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92855958 |
| 65 | Dialeptic seizures (HP:0011146) | 2.87071121 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.86876646 |
| 67 | Torticollis (HP:0000473) | 2.86171665 |
| 68 | Spastic gait (HP:0002064) | 2.81458086 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.78817028 |
| 70 | Dysmetria (HP:0001310) | 2.76048090 |
| 71 | Aplasia involving bones of the extremities (HP:0009825) | 2.74690283 |
| 72 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.74690283 |
| 73 | Aplasia of the phalanges of the hand (HP:0009802) | 2.74690283 |
| 74 | Anxiety (HP:0000739) | 2.71290586 |
| 75 | Peripheral hypomyelination (HP:0007182) | 2.69581036 |
| 76 | Skin nodule (HP:0200036) | 2.65770770 |
| 77 | Hypochromic microcytic anemia (HP:0004840) | 2.65012388 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.64858348 |
| 79 | Status epilepticus (HP:0002133) | 2.61260400 |
| 80 | Metabolic acidosis (HP:0001942) | 2.60122581 |
| 81 | Abnormality of purine metabolism (HP:0004352) | 2.59021409 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.56604054 |
| 83 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56604054 |
| 84 | Mitral stenosis (HP:0001718) | 2.55900430 |
| 85 | Limb dystonia (HP:0002451) | 2.55802565 |
| 86 | Truncal ataxia (HP:0002078) | 2.55658412 |
| 87 | Progressive cerebellar ataxia (HP:0002073) | 2.52626719 |
| 88 | Spontaneous abortion (HP:0005268) | 2.50659059 |
| 89 | Depression (HP:0000716) | 2.49820200 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.48844693 |
| 91 | Scanning speech (HP:0002168) | 2.48241448 |
| 92 | Epileptiform EEG discharges (HP:0011182) | 2.47355928 |
| 93 | Cerebral hypomyelination (HP:0006808) | 2.46908645 |
| 94 | Lethargy (HP:0001254) | 2.45517316 |
| 95 | Focal dystonia (HP:0004373) | 2.40953519 |
| 96 | Gout (HP:0001997) | 2.40710336 |
| 97 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.40097897 |
| 98 | Visual hallucinations (HP:0002367) | 2.39255721 |
| 99 | Bradykinesia (HP:0002067) | 2.36747049 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.36436839 |
| 101 | Atrioventricular block (HP:0001678) | 2.35400167 |
| 102 | Mutism (HP:0002300) | 2.34640138 |
| 103 | Papilledema (HP:0001085) | 2.34500470 |
| 104 | Megalencephaly (HP:0001355) | 2.33742241 |
| 105 | Acanthocytosis (HP:0001927) | 2.32194104 |
| 106 | Neonatal onset (HP:0003623) | 2.31864004 |
| 107 | Obstructive sleep apnea (HP:0002870) | 2.29492305 |
| 108 | Delusions (HP:0000746) | 2.29171519 |
| 109 | Split foot (HP:0001839) | 2.29132643 |
| 110 | Urinary urgency (HP:0000012) | 2.26801706 |
| 111 | Hypoglycemic seizures (HP:0002173) | 2.26512624 |
| 112 | Spastic diplegia (HP:0001264) | 2.26366456 |
| 113 | Craniofacial dystonia (HP:0012179) | 2.25452148 |
| 114 | Bundle branch block (HP:0011710) | 2.25153172 |
| 115 | Heart block (HP:0012722) | 2.24755532 |
| 116 | Clonus (HP:0002169) | 2.24581508 |
| 117 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23322394 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 2.22433913 |
| 119 | Cerebral edema (HP:0002181) | 2.21982878 |
| 120 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19574220 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.18754551 |
| 122 | Nephritis (HP:0000123) | 2.17737261 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 2.17645474 |
| 124 | Glomerulonephritis (HP:0000099) | 2.17502550 |
| 125 | Retinal atrophy (HP:0001105) | 2.17282861 |
| 126 | Poor eye contact (HP:0000817) | 2.16590067 |
| 127 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.16505541 |
| 128 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.16505541 |
| 129 | Enlarged kidneys (HP:0000105) | 2.15503413 |
| 130 | Irritability (HP:0000737) | 2.15337262 |
| 131 | Chronic hepatic failure (HP:0100626) | 2.15304080 |
| 132 | Amyloidosis (HP:0011034) | 2.14381862 |
| 133 | Alacrima (HP:0000522) | 2.13342553 |
| 134 | Cholelithiasis (HP:0001081) | 2.12664457 |
| 135 | Hyperventilation (HP:0002883) | 2.12328097 |
| 136 | Rigidity (HP:0002063) | 2.12058945 |
| 137 | Confusion (HP:0001289) | 2.08891701 |
| 138 | Polyphagia (HP:0002591) | 2.07269393 |
| 139 | Amblyopia (HP:0000646) | 2.06973609 |
| 140 | Hypsarrhythmia (HP:0002521) | 2.05977254 |
| 141 | Rickets (HP:0002748) | 2.05634244 |
| 142 | Sleep apnea (HP:0010535) | 2.03599982 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 2.02873310 |
| 144 | Gingival bleeding (HP:0000225) | 2.02638456 |
| 145 | Abnormality of the periventricular white matter (HP:0002518) | 2.00048449 |
| 146 | Fair hair (HP:0002286) | 1.99775092 |
| 147 | Menorrhagia (HP:0000132) | 1.99674464 |
| 148 | Blue irides (HP:0000635) | 1.99537761 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.98928322 |
| 150 | Alkalosis (HP:0001948) | 1.97894712 |
| 151 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97739846 |
| 152 | Hypophosphatemic rickets (HP:0004912) | 1.96447953 |
| 153 | Pancreatitis (HP:0001733) | 1.95887782 |
| 154 | Esophageal varix (HP:0002040) | 1.95372595 |
| 155 | Akinesia (HP:0002304) | 1.95174410 |
| 156 | Choreoathetosis (HP:0001266) | 1.95066135 |
| 157 | Impaired social interactions (HP:0000735) | 1.94300701 |
| 158 | Abnormal social behavior (HP:0012433) | 1.94300701 |
| 159 | Hypokalemic alkalosis (HP:0001949) | 1.93899152 |
| 160 | Abnormality of cochlea (HP:0000375) | 1.93759226 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.93487618 |
| 162 | Cholecystitis (HP:0001082) | 1.93487618 |
| 163 | Thrombophlebitis (HP:0004418) | 1.91637122 |
| 164 | Late onset (HP:0003584) | 1.87215764 |
| 165 | Cerebral hemorrhage (HP:0001342) | 1.86174990 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.86019104 |
| 167 | Abnormality of vitamin metabolism (HP:0100508) | 1.85758672 |
| 168 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83172437 |
| 169 | Vomiting (HP:0002013) | 1.82923354 |
| 170 | Abnormality of proline metabolism (HP:0010907) | 1.81220901 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.81220901 |
| 172 | Back pain (HP:0003418) | 1.80351239 |
| 173 | Opisthotonus (HP:0002179) | 1.78656714 |
| 174 | Generalized aminoaciduria (HP:0002909) | 1.77097347 |
| 175 | Malnutrition (HP:0004395) | 1.76081900 |
| 176 | Abnormality of the gallbladder (HP:0005264) | 1.75729633 |
| 177 | Poikilocytosis (HP:0004447) | 1.75423420 |
| 178 | Paraparesis (HP:0002385) | 1.74801476 |
| 179 | Pseudobulbar signs (HP:0002200) | 1.74436848 |
| 180 | Tetraplegia (HP:0002445) | 1.74150293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK2 | 8.07176868 |
| 2 | TNIK | 7.87920977 |
| 3 | MKNK1 | 4.19937345 |
| 4 | BCKDK | 3.75978411 |
| 5 | MARK1 | 3.63180662 |
| 6 | PAK6 | 3.41812936 |
| 7 | RIPK1 | 2.83461616 |
| 8 | SIK1 | 2.69698990 |
| 9 | UHMK1 | 2.52268845 |
| 10 | FGFR4 | 2.47896770 |
| 11 | CASK | 2.39137592 |
| 12 | INSRR | 2.20245524 |
| 13 | MAP3K9 | 2.15939768 |
| 14 | MAP2K4 | 2.08721538 |
| 15 | ERN1 | 1.92669631 |
| 16 | ERBB4 | 1.90199171 |
| 17 | MINK1 | 1.87201772 |
| 18 | CAMK2B | 1.74748936 |
| 19 | PLK2 | 1.70542965 |
| 20 | TAOK3 | 1.69410790 |
| 21 | MAP2K7 | 1.57138180 |
| 22 | ARAF | 1.56750992 |
| 23 | MAPK13 | 1.54572190 |
| 24 | PRKCG | 1.53415815 |
| 25 | PINK1 | 1.50074746 |
| 26 | CDK5 | 1.42996332 |
| 27 | KSR2 | 1.30130764 |
| 28 | CAMK1 | 1.25065737 |
| 29 | DAPK2 | 1.24320558 |
| 30 | SGK3 | 1.18779377 |
| 31 | PAK3 | 1.14770114 |
| 32 | TYRO3 | 1.13896199 |
| 33 | EPHA4 | 1.13589337 |
| 34 | PKN2 | 1.06296045 |
| 35 | MAPK12 | 1.05639926 |
| 36 | MAP3K4 | 1.05269212 |
| 37 | MST1R | 1.01942593 |
| 38 | PIK3CA | 1.01894478 |
| 39 | DYRK1A | 1.00214296 |
| 40 | FGFR2 | 0.98999124 |
| 41 | MAPK11 | 0.96548084 |
| 42 | CAMKK2 | 0.96332310 |
| 43 | CAMK2D | 0.93868461 |
| 44 | MAP3K7 | 0.93643905 |
| 45 | PTK6 | 0.92560792 |
| 46 | DAPK1 | 0.92350633 |
| 47 | RIPK4 | 0.91773303 |
| 48 | FES | 0.90459526 |
| 49 | SGK2 | 0.87874776 |
| 50 | MAPK10 | 0.87233188 |
| 51 | TRIB3 | 0.86193497 |
| 52 | STK11 | 0.84922404 |
| 53 | PDK2 | 0.81634274 |
| 54 | CDK15 | 0.80800728 |
| 55 | MAPK7 | 0.80520305 |
| 56 | PIK3CG | 0.79270645 |
| 57 | PRKAA2 | 0.78000563 |
| 58 | CDK18 | 0.76412360 |
| 59 | TNK2 | 0.76308415 |
| 60 | IRAK3 | 0.75218579 |
| 61 | ALK | 0.74249508 |
| 62 | JAK2 | 0.72229938 |
| 63 | LATS1 | 0.71949680 |
| 64 | CDK14 | 0.71850402 |
| 65 | MAPK4 | 0.71626063 |
| 66 | CDK11A | 0.71235662 |
| 67 | MARK2 | 0.70745830 |
| 68 | TYK2 | 0.69271748 |
| 69 | CAMK2G | 0.69102995 |
| 70 | BMPR2 | 0.68263979 |
| 71 | SIK2 | 0.68220941 |
| 72 | MAP3K13 | 0.68090289 |
| 73 | MAPKAPK5 | 0.67688421 |
| 74 | BRSK1 | 0.67674027 |
| 75 | PHKG1 | 0.67631266 |
| 76 | PHKG2 | 0.67631266 |
| 77 | LATS2 | 0.67491945 |
| 78 | SGK494 | 0.67323704 |
| 79 | SGK223 | 0.67323704 |
| 80 | OXSR1 | 0.67125552 |
| 81 | PRPF4B | 0.66588741 |
| 82 | JAK1 | 0.65290019 |
| 83 | PRKACG | 0.64520038 |
| 84 | ROCK2 | 0.63361674 |
| 85 | MAP3K14 | 0.62704595 |
| 86 | FLT3 | 0.61943020 |
| 87 | ABL2 | 0.61295915 |
| 88 | NTRK2 | 0.60895530 |
| 89 | PRKG1 | 0.59746676 |
| 90 | ERBB2 | 0.59116846 |
| 91 | FRK | 0.57538823 |
| 92 | CDK19 | 0.53375382 |
| 93 | CAMKK1 | 0.52613243 |
| 94 | PRKCZ | 0.51425475 |
| 95 | STK38 | 0.51328262 |
| 96 | PDPK1 | 0.50635281 |
| 97 | PRKACB | 0.49091633 |
| 98 | MAP3K1 | 0.48987870 |
| 99 | CAMK1D | 0.46586071 |
| 100 | TIE1 | 0.45610589 |
| 101 | PRKCH | 0.45330416 |
| 102 | IGF1R | 0.44658650 |
| 103 | BRAF | 0.44523950 |
| 104 | MAP3K2 | 0.43575348 |
| 105 | MAP2K1 | 0.42935075 |
| 106 | RPS6KB1 | 0.42773437 |
| 107 | PRKAA1 | 0.42584723 |
| 108 | AKT2 | 0.40998421 |
| 109 | CSNK1D | 0.40781645 |
| 110 | PDK1 | 0.40646593 |
| 111 | GRK6 | 0.40550551 |
| 112 | FYN | 0.40444163 |
| 113 | RET | 0.40048186 |
| 114 | PRKCA | 0.39671507 |
| 115 | PKN1 | 0.39170308 |
| 116 | TBK1 | 0.39022912 |
| 117 | SGK1 | 0.38134216 |
| 118 | PRKD1 | 0.37591597 |
| 119 | NEK9 | 0.37303682 |
| 120 | BMX | 0.36959708 |
| 121 | NTRK3 | 0.36958861 |
| 122 | RAF1 | 0.35312527 |
| 123 | TGFBR2 | 0.34661874 |
| 124 | ROCK1 | 0.34594136 |
| 125 | LMTK2 | 0.34209556 |
| 126 | MAP3K11 | 0.33245876 |
| 127 | PRKCQ | 0.32388507 |
| 128 | CAMK4 | 0.30541000 |
| 129 | CDK6 | 0.30337206 |
| 130 | PRKCB | 0.30102225 |
| 131 | MAP2K6 | 0.28504823 |
| 132 | CAMK1G | 0.28123374 |
| 133 | RPS6KA3 | 0.26393843 |
| 134 | GSK3A | 0.25717262 |
| 135 | CSNK1A1 | 0.25633253 |
| 136 | CSNK1E | 0.23692315 |
| 137 | FGFR3 | 0.23401022 |
| 138 | NTRK1 | 0.23049167 |
| 139 | PRKACA | 0.21612937 |
| 140 | EPHB1 | 0.20923195 |
| 141 | CAMK2A | 0.20858950 |
| 142 | CSNK1G2 | 0.20666685 |
| 143 | NEK6 | 0.20010204 |
| 144 | GRK5 | 0.19765488 |
| 145 | PRKD3 | 0.19320339 |
| 146 | PRKCE | 0.19083590 |
| 147 | MAPK15 | 0.17850403 |
| 148 | MUSK | 0.17186127 |
| 149 | IKBKE | 0.15256475 |
| 150 | KDR | 0.14973142 |
| 151 | CSK | 0.13865902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.47318109 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.29631265 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41205323 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.20694578 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05170590 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61205638 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59953617 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55461360 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49716369 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47147458 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.40678038 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31609297 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.22260253 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19919033 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00077709 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99766478 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.99409547 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.91733036 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90361219 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90289537 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88083865 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87197476 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86957501 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81363390 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.80659367 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80509086 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77276418 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.69471724 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68908730 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.68878324 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68046107 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.61624729 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.59647201 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56531900 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.55921973 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55514147 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53254576 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52645812 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50991050 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49827856 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44552839 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44098649 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43983845 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38971360 |
| 45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36190284 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.35003517 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28079843 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24214468 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21567074 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21255766 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21129062 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20178166 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17990738 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.17902514 |
| 55 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16724035 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15848883 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 1.15067728 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10617032 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 1.07177128 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06943602 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05668857 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.03229189 |
| 63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01101556 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 1.00074556 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96596687 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95432797 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95139536 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94062838 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.90847019 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89042821 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.89001424 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88123553 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84870763 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84396902 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83873501 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82564465 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81932784 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.78351597 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76813665 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.73793582 |
| 81 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72757078 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70825676 |
| 83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69945377 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65457746 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62802996 |
| 86 | Long-term depression_Homo sapiens_hsa04730 | 0.62687207 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58396097 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56852805 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56063837 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55714205 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55201564 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53179315 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51855385 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48612276 |
| 95 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47865921 |
| 96 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43687121 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43353292 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43026458 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.41573143 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41080030 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41014676 |
| 102 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.40658486 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37255092 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32967217 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30881705 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23004023 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.22090124 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.20987457 |
| 109 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20797720 |
| 110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19655210 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17865195 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15542671 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13524049 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13257387 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12426941 |
| 116 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10215991 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08821753 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05472305 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.04713337 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.01681962 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01387813 |
| 122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1955928 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1945280 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | -0.1900207 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.1898839 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1701536 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | -0.1688516 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1683587 |
| 129 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.1577504 |
| 130 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1521210 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1149480 |
| 132 | Nicotine addiction_Homo sapiens_hsa05033 | -0.1137506 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0934918 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0740809 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0680863 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0610484 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0602037 |

